some symptoms like dysaesthesia appear more frequently with Wegovy 7.2mg, but overall safety profile is comparable No direct head-to-head data: There is no robust, completed trial directly comparing Wegovy 7.2mg and Mounjaro 15mg, so conclusions rely on best-available indirect evidence Individual variation matters most: The strongest option for any individual is the one that offers effective weight loss with acceptable side effects, fits their health profile, and can be used consistently long-term First weight loss medications arent always the last: Some people may need to try more than one option before finding what delivers sustained weight loss for their situation These medications, whether Wegovy and Mounjaro at standard or higher doses, are tools within a wider plan
Clinical evaluation included daily assessment of lameness, defined as the inability of the rabbit to bear weight and maintain the typical flexion-extension cycle of the affected limb compared to the unaffected limb
Proc Natl Acad Sci U S A (2003) 100(25):151605.10.1073/pnas.2334159100 128 LaffitteANeiersFBriandL
Limitations of Mechanism Studies While these mechanisms are fascinating from a research perspective, they represent the beginning of understanding, not established facts about human physiology
Common issues include nausea, vomiting, diarrhea, and abdominal discomfort
